Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
about
Antiretroviral interventions for preventing breast milk transmission of HIVAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionThe Uptake of Prevention of Mother-to-Child HIV Transmission Programs in China: A Systematic Review and Meta-AnalysisAntiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan AfricaReview: [corrected] The changing face of the HIV epidemic in sub-Saharan AfricaHIV-free survival at 12-24 months in breastfed infants of HIV-infected women on antiretroviral treatmentOptimizing Infant HIV Diagnosis in Resource-Limited Settings: Modeling the Impact of HIV DNA PCR Testing at BirthEmergence and persistence of minor drug-resistant HIV-1 variants in Ugandan women after nevirapine single-dose prophylaxisWHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothersAdherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in TanzaniaWhat will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysisEmergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmissionPregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trialMaternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after deliveryWomen's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, TanzaniaPoint-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysisHIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmissionSurveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges.Analysis of HIV early infant diagnosis data to estimate rates of perinatal HIV transmission in ZambiaPooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.Maternal and foetal outcomes among 4118 women with HIV infection treated with lopinavir/ritonavir during pregnancy: analysis of population-based surveillance data from the national study of HIV in pregnancy and childhood in the United Kingdom and IrPregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment.Maternal nutritional status predicts adverse birth outcomes among HIV-infected rural Ugandan women receiving combination antiretroviral therapy.Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT.Beyond prevention of mother-to-child transmission: keeping HIV-exposed and HIV-positive children healthy and aliveTherapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana.What influences feeding decisions for HIV-exposed infants in rural Kenya?Individualizing the WHO HIV and infant feeding guidelines: optimal breastfeeding duration to maximize infant HIV-free survivalThe cost-effectiveness of different feeding patterns combined with prompt treatments for preventing mother-to-child HIV transmission in South Africa: estimates from simulation modeling.Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study.HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periodsUniversal combination antiretroviral regimens to prevent mother-to-child transmission of HIV in rural Zambia: a two-round cross-sectional studyBirth weight for gestational age norms for a large cohort of infants born to HIV-negative women in Botswana compared with norms for U.S.-born black infants.Incidence and correlates of HIV-1 RNA detection in the breast milk of women receiving HAART for the prevention of HIV-1 transmission.Virtual Elimination of Mother-to-Child Transmission of Human Immunodeficiency Virus in Mothers on Highly Active Antiretroviral Therapy in Enugu, South-Eastern NigeriaViral sequence analysis of HIV-positive women and their infected children: insight on the timing of infection and on the transmission network.Development of an AFASS assessment and screening tool towards the prevention of mother-to-child HIV transmission (PMTCT) in sub-Saharan Africa--a Delphi surveyAntenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.Breast milk from Tanzanian women has divergent effects on cell-free and cell-associated HIV-1 infection in vitroCommunity-based evaluation of PMTCT uptake in Nyanza Province, Kenya.
P2860
Q22252958-223AD8EA-F9A7-4A32-AB49-05813080194CQ24235500-AE193099-C2EB-41F8-BA8B-0B24ECB9612EQ26797286-31231471-E8BA-4018-AA4C-D4598B76A7A5Q27014960-DF515594-41CB-40AC-9D46-5BFB9CBC757DQ27022927-15719E58-6DB5-4BE2-AC01-8084BC64F27AQ28070420-D0DC5D93-8ECE-47EA-B646-44812A9AECECQ28365388-F9788D1E-4C99-43CD-9FB6-91A6DCE1DBC8Q28478377-9ED16E11-70D8-4394-B819-1875CC035D4AQ28478406-3DEEF508-0128-49BE-AB9D-926763026A80Q28478531-A29BF048-9DBE-42EC-B3FA-B9C132FD4386Q28478769-DFB948BC-B933-4C0E-82F0-EA8CD01F7098Q28481233-27F551BE-6BEB-4B2B-940B-F0DAEFC5FB9BQ28483723-7A67E0B9-9CA0-493B-9CBA-EFDB9F3BD00FQ28534751-1B69CD43-3C9D-42DD-A507-49BCE37BF633Q28538970-701D04FC-4B68-4BF3-B47F-A2B6E1CF5BBDQ28543954-43FAB8B2-3581-43E2-95E2-5BD4510B8F02Q28660329-BBADC093-656C-4A39-94BE-7AA376D4C896Q30244368-B4F74D68-06D3-4C3B-B59A-896C39927A4CQ30558708-3C92124C-23B1-4EFC-87DA-9B0AAB834C03Q30569674-DB7DB138-E977-4913-974E-EE7AA411075EQ31043161-FEEC2090-A6A4-49D6-92AB-E3ED104C1BE2Q31043326-A83F1364-281E-495E-81D5-38D3C5F6D21EQ31081091-A6340F9D-3EE1-4EEA-BFF8-431D50C60AFCQ33745946-1AB4D87D-DAF0-4D9A-891A-FD0D1092FD04Q33865236-FD999609-A723-4073-8B2A-7245FD7FF44AQ33887266-E9190BDD-130D-4E9E-B47E-72B662DC0B91Q33901535-A225826C-6793-4609-8557-F597F1B002ABQ33902803-A1BE4BBE-3966-4B7B-82B7-F719177A3D16Q33940190-335DDE33-29E9-4AB3-B6B8-CD7AEAA18885Q33946645-50D8D733-FA11-4CCD-93D5-0F05974E99F0Q34081657-AE0FC914-16B0-4D97-BBA8-B2A82FB74E48Q34101340-9826E6BD-88D3-4E00-BF5A-92FE0FA45991Q34104017-00DD0CA1-AAFB-4052-884A-18BCEEF93B61Q34130621-83592858-9534-48CC-BD00-4A03E5C64A66Q34162417-CAB09CBC-6647-4550-B600-5E610F18C652Q34266269-9C40BBAA-F337-430F-8F6A-14736A23DC76Q34294426-4E6E840C-B870-4E6D-9A84-79FFF0B6D729Q34310482-6B9E4456-FD1E-4159-BA9B-F1F16A8B324CQ34405618-2083C37A-2735-4249-B5B0-97163FAF2751Q34434132-EF322434-79C7-4BCA-8CC4-B1405E94DC40
P2860
Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Triple antiretroviral compared ...... a randomised controlled trial.
@en
type
label
Triple antiretroviral compared ...... a randomised controlled trial.
@en
prefLabel
Triple antiretroviral compared ...... a randomised controlled trial.
@en
P921
P1476
Triple antiretroviral compared ...... a randomised controlled trial.
@en
P2093
Isabelle de Vincenzi
Kesho Bora Study Group
P304
P356
10.1016/S1473-3099(10)70288-7
P577
2011-01-13T00:00:00Z